Past, Present, and Future of Bioequivalence: Improving Assessment and Extrapolation of Therapeutic Equivalence for Oral Drug Products
- 1 October 2018
- journal article
- editorial
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 107 (10) , 2519-2530
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- A History of Biopharmaceutics in the Food and Drug Administration 1968–1993The AAPS Journal, 2009
- In Vitro Studies are Sometimes Better than Conventional Human Pharmacokinetic In Vivo Studies in Assessing Bioequivalence of Immediate-Release Solid Oral Dosage FormsThe AAPS Journal, 2008
- Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug ApplicationsThe AAPS Journal, 2008
- The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBritish Journal of Clinical Pharmacology, 2007
- Changes in prescribed drug doses after market introductionPharmacoepidemiology and Drug Safety, 2002
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- Bioavailability and BioequivalenceThe Journal of Clinical Pharmacology, 1976
- Drug bioequivalenceJournal of Pharmacokinetics and Biopharmaceutics, 1974
- Bioavailability of DrugsCirculation, 1974